Acute lymphoblastic leukemia: Survey of immunophenotype, French- American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases

American Journal of Clinical Pathology

Volumn 111, Issue 4, 1999, Pages 467-476

  Khalidi, Hasan S ^a   Chang, Karen L ^a   Medeiros, L Jeffrey ^a   Brynes, Russell K ^a   Slovak, Marilyn L ^a   Murata Collins, Joyce L ^a   Arber, Daniel A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Cytogenetics; Flow cytometry; French American British Cooperative Group classification; Immunophenotyping; Myeloid antigens

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CHILD; CHROMOSOME 11Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; FEMALE; HUMAN; IMMUNOPHENOTYPING; INFANT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0033054730     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.4.467     Document Type: Article

References (45)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO). Br J Haematol. 1991;78:325-329.
2. Sallan SE, Ritz J, Pesando J, et al. Cell surface antigens: prognostic implication in childhood acute lymphoblastic leukemia. Blood. 1980;55:395-402.
3. Greaves MF, Lister TA. Prognostic importance of immunologic markers in adult lymphoblastic leukemia. N Engl J Med. 1981;304:119-120.
4. Borowitz MJ. Immunologic markers in childhood lymphoblastic leukemia. Hematol Oncol Clin North Am. 1990;4:743-765.
5. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemia. Leukemia. 1995;9:1783-1786.
6. Traweck ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol. 1993;99:504-512.
7. Rennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol. 1981;47:553-561.
8. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
9. Mitelman F, ed. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S Karger; 1995.
10. Khalidi HS, O'Donnell MR, Slovak ML, et al. Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis. Cancer Genet Cytogenet. 1999;109:58-65.
11. Kalwinski DK, Roberson P, Dahl G, et al. Clinical relevance of lymphoblast biological features in children with acute lymphohlastic leukemia. J Clin Oncol. 1985;3:477-484.
12. Neame PB, Soamboonsrup P, Browman GP, et al. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood. 1986;68:1355-1362.
13. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood. 1986;68:1-31.
14. Catovsky O, Matutes E, Buccheri V, et al. A classification of acute leukemia for the 1990s. Ann Hematol. 1991;62:16-21.
15. Pui C-H. Childhood leukemias. N Engl J Med. 1995;332:1618-1630.
16. Sobol RE, Mick R, Royston I, et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med. 1987;316:1111-1117.
17. Urbano-Ispizua A, Matutes E, Villamor N, et al. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Hoematol. 1990;75:202-207.
18. Wiersma SR, Ortega J, Sobel E, et al. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med. 1991;324:800-808.
19. Drexler HG, Thiel E, Ludwig W-D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia. 1991;5:637-645.
20. Boldt DH, Kopecky KJ, Head D, et al. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group experience. Leukemia. 1994;8:2118-2126.
21. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151-1168.
22. Pui C-H, Behm FG, Singh B, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood. 1990;75:198-202.
23. Uckun FM, Sather HN, Gaynon PS, et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 1997;90:28-35.
24. Dinndorf PA, Andrews RG, Benjamin D, et al. Expression of normal myeloid-associated antigens by acute leukemia. Blood 1986;67:1048-1053.
25. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia. 1989;3:170-181.
26. Davey FR, Mick R, Nelson DA, et al. Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. Leukemia. 1988;2:420-426.
27. Childs CC, Hirsch-Ginsberg C, Walters RS, et al. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics. Leukemia. 1989;3:777-783.
28. Ross CW, Stoolman LM, Schnitzer B, et al. Immunophenotypic aberrancy in adult acute lymphoblastic leukemia. Am J Clin Pathol. 1990;94:590-599.
29. Guyotat D, Campos L, Shi Z-H, et al. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia. 1990;4:664-666.
30. Buccheri V, Matutes E, Dyer MJS, et al. Lineage commitment in biphenotypic acute leukemia. Leukemia. 1993;7:919-927.
31. Lauria F, Raspadori D, Martinelli G, et al. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukemia patients: diagnostic and prognostic implications. Br J Haematol. 1994;87:286-292.
32. Nakase K, Kenkichi K, Shiku H, et al. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms. Am J Clin Pathol. 1996;105:761-768.
33. Rothe G, Schmitz G, Adorf D, et al. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia. 1996;10:877-895.
34. Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol. 1998;109:211-220.
35. Wells SJ, Bray RA, Stempora LL, et al. CD117/CD34 expression in leukemic blasts. Am J Clin Pathol. 1996;106:192-195.
36. Pui C-H, Raimondi SC, Head DR, et al. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood. 1991;78:1327-1337.
37. Pui C-H, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood. 1993;82:343-362.
38. Vaughan WP, Civin CI, Weisenburger DD, et al. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia. 1988;2:661-666.
39. Viana MB, Maurer HS, Ferenc C. Subclassification of acute lymphoblastic leukaemia in children: analysis of the reproducibility of morphological criteria and prognostic implications. Br J Haematol. 1980;44:383-388.
40. Reid MM, Proctor SJ. Failure of FAB classification to predict relapse-free survival in acute leukaemia. Lancet. 1982;2:153-154.
41. Davey FR, Castella A, Lauenstein K, et al. Prognostic significance of the revised French-American-British classification for acute lymphocytic leukemia. Clin Lab Haematol. 1983;5:343-351.
42. Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990;76:1449-1463.
43. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia. 1996;10:74-82.
44. Raimondi SC, Behm FG, Roberson PK, et al. Cytogenetics of T-cell leukemia. Blood. 1988;72:1560-1566.
45. Borkhardt A, Cazzaniga G, Viehmann S, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood. 1997;90:571-577.